Silk Road Medical appoints Tammy Leitsinger to serve as vice president, Medical Affairs and Professional Education

134

Silk Road Medical has announced the appointment of Tammy Leitsinger to the position of vice president, Medical Affairs and Professional Education. In this new role, Leitsinger will further develop and refine global, peer-to-peer transcarotid artery revascularisation (TCAR) training pathways and innovative educational programmes.

Prior to joining Silk Road Medical, Leitsinger was vice president, Global Clinical Solutions, Cordis Corporation, Cardinal Health and has over 25 years of clinical education and global market development in the endovascular, cardiovascular, neurovascular and endoscopy arenas and has a profound understanding of carotid revascularisation via transfemoral carotid artery stenting (TF-CAS).

“Tammy has an absolutely stellar reputation with both industry and physician key opinion leaders in our vascular domain. Tammy also brings in-depth expertise in global healthcare compliance policy and government regulations which will serve Silk Road Medical well as we commercialise TCAR at an accelerated pace,” said Sumaira Macdonald, chief medical officer, Silk Road Medical.

“The quest for a minimally invasive, endovascular solution for patients with carotid artery disease has been extensive and challenging due to the high risk of devastating complications,” said Leitsinger. “The TCAR procedure addresses these legacy risks and is clearly the pathway forward. I look forward to working with the team to help drive TCAR to standard of care for carotid disease patients at risk for traditional surgery.”

TCAR is a clinically-proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS) during the TCAR procedure. The ENROUTE Transcarotid NPS is a first-in-class device used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.

(Visited 70 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here